[Therapy of cerebral infarction by infusion of plasma substitutes].
In a total of 152 cases of severe cerebral infarction intravascular infusion of plasma substitutes was a part of combined therapy. Hemostasis studies in these patients allowed us to detect various degrees of hypercoagulation as a response to hemodilution. In cases of most pronounced post-hemodilution++ hypercoagulation (77 patients) complications, including those of thrombohemorrhagic nature, were increased in rate (74%) with more severe course of cerebral infarction. Of these 77 patients 46 died (59.7%). In 75 cases with no substantial hypercoagulation, the disease had a more benign course with 2 casulties (2.7%). The hemodilution tests should precede the therapeutic use of plasma substitutes in cerebral infarct patients.
Vasilenko
F I
FI
D001780:Blood Coagulation Tests; D002544:Cerebral Infarction / Q000097:blood / Q000150:complications / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D005440:Fluid Therapy; D006438:Hemodilution; D006801:Humans; D008297:Male; D010952:Plasma Substitutes / Q000008:administration & dosage*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D010952:Plasma Substitutes
Ob infuzionnoĭ terapii plazmozameshchaiushchimi zhidkostiami infarktov miokarda.